Felix Y. Feng

50.6k total citations · 6 hit papers
444 papers, 16.2k citations indexed

About

Felix Y. Feng is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology. According to data from OpenAlex, Felix Y. Feng has authored 444 papers receiving a total of 16.2k indexed citations (citations by other indexed papers that have themselves been cited), including 330 papers in Pulmonary and Respiratory Medicine, 134 papers in Cancer Research and 97 papers in Oncology. Recurrent topics in Felix Y. Feng's work include Prostate Cancer Treatment and Research (290 papers), Prostate Cancer Diagnosis and Treatment (175 papers) and Cancer, Lipids, and Metabolism (60 papers). Felix Y. Feng is often cited by papers focused on Prostate Cancer Treatment and Research (290 papers), Prostate Cancer Diagnosis and Treatment (175 papers) and Cancer, Lipids, and Metabolism (60 papers). Felix Y. Feng collaborates with scholars based in United States, Canada and United Kingdom. Felix Y. Feng's co-authors include Arul M. Chinnaiyan, Joseph R. Evans, Xuhong Cao, Shuang G. Zhao, Rohit Malik, John R. Prensner, Yi-Mi Wu, Avraham Eisbruch, Matthew K. Iyer and Saravana M. Dhanasekaran and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Felix Y. Feng

422 papers receiving 16.1k citations

Hit Papers

The landscape of long noncoding RNAs in the human transcr... 2014 2026 2018 2022 2015 2014 2021 2018 2016 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The landscape of long noncoding RNAs in the human transcriptome
    2015 2.1k citations Matthew K. Iyer, Yashar S. Niknafs et al. profile →
  2. Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer
    2014 737 citations Irfan A. Asangani, Vijaya L. Dommeti et al. profile →
  3. Long noncoding RNAs in cancer metastasis
    2021 441 citations Ha X. Dang, Felix Y. Feng et al. profile →
  4. Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer
    2018 384 citations Robert J. Lonigro, Xuhong Cao et al. profile →
  5. Contemporary Update of a Multi-Institutional Predictive Nomogram for Salvage Radiotherapy After Radical Prostatectomy
    2016 229 citations Felix Y. Feng, Robert B. Den et al. profile →
  6. Single-cell analysis of human primary prostate cancer reveals the heterogeneity of tumor-associated epithelial cell states
    2022 140 citations Felix Y. Feng et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Felix Y. Feng United States 63 7.4k 7.3k 6.2k 3.3k 1.9k 444 16.2k
Catharine West United Kingdom 62 5.3k 0.7× 3.3k 0.4× 5.0k 0.8× 3.0k 0.9× 1.5k 0.8× 321 13.3k
Michael I. Koukourakis Greece 60 6.1k 0.8× 2.6k 0.4× 5.0k 0.8× 3.9k 1.2× 1.2k 0.6× 332 13.0k
Alexandra Giatromanolaki Greece 65 7.6k 1.0× 2.8k 0.4× 5.9k 1.0× 4.2k 1.3× 1.5k 0.8× 389 15.3k
Dora L.�W. Kwong Hong Kong 53 3.3k 0.4× 3.0k 0.4× 2.4k 0.4× 3.4k 1.0× 3.5k 1.9× 219 11.1k
David Raben United States 48 4.4k 0.6× 5.6k 0.8× 1.8k 0.3× 6.8k 2.1× 3.7k 1.9× 236 15.2k
Bruce G. Haffty United States 71 4.6k 0.6× 3.0k 0.4× 10.7k 1.7× 8.1k 2.4× 4.0k 2.1× 538 20.6k
Timothy A. Chan United States 77 9.4k 1.3× 5.5k 0.8× 5.2k 0.8× 10.4k 3.1× 2.0k 1.0× 243 22.7k
Nadeem Riaz United States 47 2.4k 0.3× 2.4k 0.3× 2.0k 0.3× 4.6k 1.4× 1.6k 0.8× 243 9.2k
Simon N. Powell United States 66 6.5k 0.9× 2.0k 0.3× 4.8k 0.8× 5.0k 1.5× 1.6k 0.8× 278 13.1k
Christine H. Chung United States 52 4.7k 0.6× 3.6k 0.5× 2.4k 0.4× 5.6k 1.7× 4.5k 2.4× 255 15.6k

Countries citing papers authored by Felix Y. Feng

Since Specialization
Citations

This map shows the geographic impact of Felix Y. Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Felix Y. Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Felix Y. Feng more than expected).

Fields of papers citing papers by Felix Y. Feng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Felix Y. Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Felix Y. Feng. The network helps show where Felix Y. Feng may publish in the future.

Co-authorship network of co-authors of Felix Y. Feng

This figure shows the co-authorship network connecting the top 25 collaborators of Felix Y. Feng. A scholar is included among the top collaborators of Felix Y. Feng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Felix Y. Feng. Felix Y. Feng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Spratt, Daniel E., Angela Y. Jia, Trevor J. Royce, et al.. (2024). Meta-analysis of Individual Patient-level Data for a Multimodal Artificial Intelligence Biomarker in High-risk Prostate Cancer: Results from Six NRG/RTOG Phase 3 Randomized Trials. European Urology. 86(4). 369–371. 1 indexed citations
2.
Sutera, Philip, Amol C. Shetty, Yang Song, et al.. (2023). Identification of a Predictive Genomic Biomarker for Prostate-directed Therapy in Synchronous Low-volume Metastatic Castration-sensitive Prostate Cancer. European Urology Oncology. 7(2). 241–247. 6 indexed citations
3.
Feng, Felix Y., Branko Miladinović, Ke Zhang, et al.. (2023). Early Endpoints in High-risk Localized Prostate Cancer: Exploratory Analysis of Three Radiation Therapy Oncology Group Phase 3 Studies. European Urology. 84(3). 331–340. 2 indexed citations
4.
Carretero-González, Alberto, Jun Zhu, Emily A. Egusa, et al.. (2023). Theranostic Targeting of CUB Domain–Containing Protein 1 (CDCP1) in Multiple Subtypes of Bladder Cancer. Clinical Cancer Research. 29(7). 1232–1242. 6 indexed citations
5.
Siefert, Joseph C., B. Cioni, Mauro J. Muraro, et al.. (2021). The Prognostic Potential of Human Prostate Cancer-Associated Macrophage Subtypes as Revealed by Single-Cell Transcriptomics. Molecular Cancer Research. 19(10). 1778–1791. 22 indexed citations
6.
Eteleeb, Abdallah M., David A. Quigley, Shuang G. Zhao, et al.. (2020). SV-HotSpot: detection and visualization of hotspots targeted by structural variants associated with gene expression. Scientific Reports. 10(1). 15890–15890. 2 indexed citations
7.
Aggarwal, Rahul, Michael T. Schweizer, David M. Nanus, et al.. (2020). A Phase Ib/IIa Study of the Pan-BET Inhibitor ZEN-3694 in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer. Clinical Cancer Research. 26(20). 5338–5347. 97 indexed citations
8.
Li, Yingming, Rendong Yang, Christine Henzler, et al.. (2020). Diverse AR Gene Rearrangements Mediate Resistance to Androgen Receptor Inhibitors in Metastatic Prostate Cancer. Clinical Cancer Research. 26(8). 1965–1976. 62 indexed citations
9.
Chou, Jonathan, David A. Quigley, Troy M. Robinson, Felix Y. Feng, & Alan Ashworth. (2020). Transcription-Associated Cyclin-Dependent Kinases as Targets and Biomarkers for Cancer Therapy. Cancer Discovery. 10(3). 351–370. 214 indexed citations
10.
Puttonen, Henri, Martin Sjöström, Erik Holmberg, et al.. (2020). Immune Infiltrate in the Primary Tumor Predicts Effect of Adjuvant Radiotherapy in Breast Cancer; Results from the Randomized SweBCG91RT Trial. Clinical Cancer Research. 27(3). 749–758. 17 indexed citations
11.
Sjöström, Martin, S. Laura Chang, Nick Fishbane, et al.. (2019). Comprehensive Transcriptomic Profiling Identifies Breast Cancer Patients Who May Be Spared Adjuvant Systemic Therapy. Clinical Cancer Research. 26(1). 171–182. 12 indexed citations
12.
Singhal, Udit, Yugang Wang, James Henderson, et al.. (2018). Multigene Profiling of CTCs in mCRPC Identifies a Clinically Relevant Prognostic Signature. Molecular Cancer Research. 16(4). 643–654. 27 indexed citations
13.
Yang, David D., Anna Krasnova, Kevin T. Nead, et al.. (2017). Androgen deprivation therapy and risk of rheumatoid arthritis in patients with localized prostate cancer. Annals of Oncology. 29(2). 386–391. 22 indexed citations
14.
Spratt, Daniel E., Tiffany Chan, Levi Waldron, et al.. (2016). Racial/Ethnic Disparities in Genomic Sequencing. JAMA Oncology. 2(8). 1070–1070. 220 indexed citations
15.
Wahl, Daniel, Joseph Dresser, Kari Wilder-Romans, et al.. (2016). Glioblastoma Therapy Can Be Augmented by Targeting IDH1-Mediated NADPH Biosynthesis. Cancer Research. 77(4). 960–970. 67 indexed citations
16.
Asangani, Irfan A., Kari Wilder-Romans, Vijaya L. Dommeti, et al.. (2016). BET Bromodomain Inhibitors Enhance Efficacy and Disrupt Resistance to AR Antagonists in the Treatment of Prostate Cancer. Molecular Cancer Research. 14(4). 324–331. 127 indexed citations
17.
Zhao, Shuang G., Joseph R. Evans, Vishal Kothari, et al.. (2015). The Landscape of Prognostic Outlier Genes in High-Risk Prostate Cancer. Clinical Cancer Research. 22(7). 1777–1786. 43 indexed citations
18.
Malik, Rohit, Lalit R. Patel, John R. Prensner, et al.. (2014). The lncRNA PCAT29 Inhibits Oncogenic Phenotypes in Prostate Cancer. Molecular Cancer Research. 12(8). 1081–1087. 112 indexed citations
19.
Goodwin, Jonathan F., Matthew J. Schiewer, Jeffry L. Dean, et al.. (2013). A Hormone–DNA Repair Circuit Governs the Response to Genotoxic Insult. Cancer Discovery. 3(11). 1254–1271. 265 indexed citations
20.
Brenner, J. Chad, Felix Y. Feng, Sumin Han, et al.. (2012). PARP-1 Inhibition as a Targeted Strategy to Treat Ewing's Sarcoma. Cancer Research. 72(7). 1608–1613. 206 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Catharine West Breakdown of academic impact, for papers by Michael I. Koukourakis Breakdown of academic impact, for papers by Alexandra Giatromanolaki Breakdown of academic impact, for papers by Dora L.�W. Kwong Breakdown of academic impact, for papers by David Raben Breakdown of academic impact, for papers by Bruce G. Haffty Breakdown of academic impact, for papers by Timothy A. Chan Breakdown of academic impact, for papers by Nadeem Riaz Breakdown of academic impact, for papers by Simon N. Powell Breakdown of academic impact, for papers by Christine H. Chung
Rankless by CCL
2026